Why are my palms getting darker?

Darkening palms can result from various causes including hyperpigmentation, medical conditions like Addison's disease or diabetes, medication side effects, or nutritional deficiencies. While often harmless, persistent palm darkening warrants medical evaluation to rule out underlying health issues.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Palm Discoloration

Noticing that your palms are getting darker can be concerning, especially when the change happens gradually or suddenly without an obvious cause. Palm discoloration, medically known as palmar hyperpigmentation, occurs when excess melanin accumulates in the skin of your hands. While this condition is often harmless, it can sometimes signal underlying health issues that require attention.

The skin on your palms is unique compared to other areas of your body. It lacks sebaceous glands and has a thicker epidermis, making it more resistant to environmental damage but also more prone to certain types of discoloration. Understanding why your palms are darkening requires examining various potential causes, from benign conditions to more serious health concerns.

Common Causes of Darkening Palms

Post-Inflammatory Hyperpigmentation

One of the most common causes of palm darkening is post-inflammatory hyperpigmentation (PIH). This occurs when your skin produces excess melanin in response to injury, irritation, or inflammation. Activities that cause repeated friction or pressure on your palms, such as manual labor, weightlifting, or using tools without gloves, can trigger this type of discoloration. The darkening typically appears in patches corresponding to areas of greatest friction.

Addison's Disease Symptoms and Stages

Addison's disease progresses gradually, with skin darkening often being an early sign.
StageCortisol LevelsSkin ChangesOther Symptoms
EarlyEarly StageSlightly decreasedMild palm darkeningFatigue, salt cravings
ModerateModerateSignificantly lowNoticeable hyperpigmentationWeight loss, low blood pressure, nausea
AdvancedAdvanced/CrisisCritically lowSevere darkeningSevere weakness, confusion, shock

Addison's disease progresses gradually, with skin darkening often being an early sign.

Chemical and Environmental Exposure

Regular contact with certain chemicals, dyes, or metals can cause palm discoloration. Common culprits include hair dyes, self-tanning products, certain cleaning agents, and metals like silver or copper. Even seemingly harmless substances like newspaper ink or certain foods high in carotenoids (like carrots or sweet potatoes) can temporarily stain your palms if handled frequently.

Genetic and Ethnic Factors

Some individuals are genetically predisposed to developing darker pigmentation on their palms and soles. This is particularly common in people with darker skin tones and is considered a normal variation. Familial acral hyperpigmentation is a benign hereditary condition where darkening of the palms and soles runs in families without any associated health problems.

Medical Conditions Associated with Palm Darkening

Addison's Disease

Addison's disease, a disorder of the adrenal glands, is one of the most serious conditions that can cause palm darkening. When your adrenal glands don't produce enough cortisol and aldosterone, your pituitary gland compensates by producing more ACTH (adrenocorticotropic hormone), which stimulates melanin production. This results in hyperpigmentation, particularly noticeable in skin creases, palms, and areas exposed to friction.

If you suspect Addison's disease, monitoring your cortisol levels is crucial for proper diagnosis and management. Regular testing can help identify adrenal insufficiency early, allowing for timely intervention and treatment.

Diabetes and Insulin Resistance

Acanthosis nigricans, a skin condition characterized by dark, velvety patches, can affect the palms in people with diabetes or insulin resistance. This condition occurs when high insulin levels stimulate skin cell growth and melanin production. The darkening often appears in skin folds and creases, including the palmar creases, and may be accompanied by a thickened, velvety texture.

Monitoring your metabolic health through regular testing of glucose and HbA1c levels can help identify insulin resistance before it progresses to diabetes. Early detection allows for lifestyle interventions that can reverse or slow the progression of metabolic dysfunction.

Thyroid Disorders

Both hyperthyroidism and hypothyroidism can cause changes in skin pigmentation, including darkening of the palms. Thyroid hormones play a crucial role in skin cell turnover and melanin production. When thyroid function is disrupted, it can lead to various skin changes, including hyperpigmentation, dryness, and changes in skin texture.

Nutritional Deficiencies and Palm Discoloration

Several nutritional deficiencies can contribute to palm darkening. Vitamin B12 deficiency, in particular, is known to cause hyperpigmentation of the palms and soles. This occurs because B12 deficiency affects melanin distribution in the skin. Iron deficiency anemia can also cause skin changes, including a grayish or darker appearance of the palms.

Pellagra, caused by niacin (vitamin B3) deficiency, presents with the classic 4 Ds: dermatitis, diarrhea, dementia, and death if untreated. The dermatitis often includes hyperpigmentation of sun-exposed areas and pressure points, including the palms. While rare in developed countries, it can occur in people with severely restricted diets or certain medical conditions affecting nutrient absorption.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Medication-Induced Palm Darkening

Certain medications can cause hyperpigmentation as a side effect, including darkening of the palms. Common medications associated with this include:

  • Antimalarial drugs (chloroquine, hydroxychloroquine)
  • Chemotherapy agents (bleomycin, doxorubicin, 5-fluorouracil)
  • Antibiotics (minocycline, tetracycline)
  • Antipsychotic medications (chlorpromazine)
  • Oral contraceptives and hormone replacement therapy
  • Some blood pressure medications (diltiazem, amlodipine)

The mechanism varies by medication but often involves either direct stimulation of melanocytes, deposition of the drug or its metabolites in the skin, or photosensitivity reactions. If you've recently started a new medication and noticed palm darkening, consult your healthcare provider about whether this could be a side effect.

When to Seek Medical Attention

While palm darkening is often benign, certain signs warrant medical evaluation. Seek medical attention if you experience:

  • Sudden or rapid darkening of palms without obvious cause
  • Darkening accompanied by fatigue, weight loss, or weakness
  • Changes in skin texture along with discoloration
  • Darkening that spreads to other body parts
  • Associated symptoms like excessive thirst, frequent urination, or dizziness
  • Palm darkening along with changes in nail color or texture

Your doctor may recommend blood tests to check for underlying conditions such as adrenal insufficiency, thyroid disorders, diabetes, or nutritional deficiencies. These tests might include cortisol levels, thyroid function tests, fasting glucose, HbA1c, vitamin B12, and iron studies.

Diagnosis and Testing Approaches

Diagnosing the cause of palm darkening typically begins with a thorough medical history and physical examination. Your healthcare provider will ask about the onset and progression of the discoloration, associated symptoms, medication history, occupational exposures, and family history of similar conditions.

Laboratory testing plays a crucial role in identifying underlying causes. Common tests include complete blood count (CBC) to check for anemia, comprehensive metabolic panel for kidney and liver function, thyroid function tests (TSH, Free T3, Free T4), cortisol levels for adrenal function, vitamin B12 and folate levels, and fasting glucose or HbA1c for diabetes screening.

In some cases, a skin biopsy may be necessary to rule out rare conditions or confirm specific diagnoses. Wood's lamp examination can help differentiate between different types of pigmentation changes. If you have existing blood test results, you can get them analyzed for free using SiPhox Health's upload service to better understand your biomarker patterns and potential underlying causes.

Treatment Options and Management Strategies

Addressing Underlying Conditions

The most effective treatment for palm darkening is addressing the underlying cause. If the discoloration is due to Addison's disease, hormone replacement therapy with hydrocortisone and fludrocortisone can help normalize pigmentation over time. For diabetes-related acanthosis nigricans, improving blood sugar control through diet, exercise, and medication can reduce hyperpigmentation.

Nutritional deficiencies should be corrected through supplementation and dietary changes. Vitamin B12 injections or high-dose oral supplements can reverse B12 deficiency-related hyperpigmentation within weeks to months. Iron supplementation for anemia should be guided by blood tests to avoid iron overload.

Topical Treatments

For cosmetic improvement of benign hyperpigmentation, several topical treatments may help:

  • Hydroquinone creams (2-4%) to inhibit melanin production
  • Retinoids to increase cell turnover and reduce pigmentation
  • Kojic acid or azelaic acid as gentler alternatives to hydroquinone
  • Vitamin C serums for their antioxidant and brightening effects
  • Chemical peels with glycolic or salicylic acid under dermatological supervision

These treatments require consistent use over several months to see results and should be combined with sun protection to prevent further darkening. Always consult a dermatologist before starting any skin-lightening regimen, as improper use can cause irritation or paradoxical darkening.

Prevention Strategies for Palm Darkening

Preventing palm darkening involves protecting your hands from known triggers and maintaining overall health. Wear gloves when handling chemicals, dyes, or doing manual work that causes friction. Use barrier creams if gloves aren't practical for your activities. Apply sunscreen to your hands daily, even though palms are less susceptible to UV damage than other skin areas.

Maintain optimal nutrition through a balanced diet rich in vitamins and minerals. Stay hydrated and moisturize your hands regularly to maintain skin barrier function. If you have risk factors for metabolic conditions, regular health screening can catch problems early before they manifest as skin changes.

Living with Hyperpigmented Palms

For many people, darker palms are a cosmetic concern rather than a medical issue. If your palm darkening is benign and doesn't respond to treatment, learning to accept this variation in your skin can be important for psychological well-being. Remember that skin color variations are normal and don't define your health or worth.

If the appearance bothers you, cosmetic camouflage makeup designed for covering hyperpigmentation can provide temporary coverage for special occasions. Choose products that are non-comedogenic and designed for use on hands, as regular foundation may transfer easily.

The Importance of Regular Health Monitoring

Palm darkening can be an early sign of various health conditions, making it a valuable warning signal from your body. Regular health monitoring through blood tests and physical examinations can help identify underlying issues before they become serious. Pay attention to changes in your body and don't dismiss seemingly minor symptoms like skin discoloration.

Consider keeping a health journal documenting when you first noticed the palm darkening, any associated symptoms, and factors that seem to make it better or worse. This information can be invaluable for your healthcare provider in determining the cause and appropriate treatment. Remember that early detection and intervention often lead to better outcomes for most health conditions.

References

  1. Patel, A. B., Kubba, R., & Kubba, A. (2013). Clinicopathological correlation of acquired hyperpigmentary disorders. Indian Journal of Dermatology, Venereology, and Leprology, 79(3), 367-375.[PubMed][DOI]
  2. Sarkar, R., Arora, P., & Garg, K. V. (2013). Cosmeceuticals for hyperpigmentation: What is available? Journal of Cutaneous and Aesthetic Surgery, 6(1), 4-11.[PubMed][DOI]
  3. Nieman, L. K., & Chanco Turner, M. L. (2006). Addison's disease. Clinics in Dermatology, 24(4), 276-280.[PubMed][DOI]
  4. Phiske, M. M. (2014). An approach to acanthosis nigricans. Indian Dermatology Online Journal, 5(3), 239-249.[PubMed][DOI]
  5. Kanwar, A. J., & Dogra, S. (2004). Acquired palmoplantar keratoderma. Indian Journal of Dermatology, Venereology, and Leprology, 70(5), 283-286.[PubMed]
  6. Gillbro, J. M., & Olsson, M. J. (2011). The melanogenesis and mechanisms of skin-lightening agents - existing and new approaches. International Journal of Cosmetic Science, 33(3), 210-221.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my cortisol at home?

You can test your cortisol at home with SiPhox Health's Stress, Energy & Sleep Rhythm Cortisol test. This test measures cortisol levels at three points throughout the day to assess your adrenal function and stress response patterns.

Is palm darkening always a sign of disease?

No, palm darkening is not always a sign of disease. Many cases are benign and result from friction, genetic factors, or harmless environmental exposures. However, sudden or progressive darkening, especially with other symptoms, should be evaluated by a healthcare provider.

How long does it take for palm darkening to resolve after treatment?

Resolution time varies depending on the cause. Medication-induced darkening may fade within weeks to months after stopping the drug. Nutritional deficiency-related darkening typically improves within 2-3 months of supplementation. Friction-related hyperpigmentation may take 6-12 months to fade completely.

Can palm darkening be prevented?

Some causes of palm darkening can be prevented by wearing protective gloves during manual work, maintaining good nutrition, managing underlying health conditions, and avoiding known triggers. However, genetic predisposition to hyperpigmentation cannot be prevented.

Should I stop my medication if it's causing palm darkening?

Never stop prescribed medication without consulting your healthcare provider. While some medications can cause hyperpigmentation, the benefits often outweigh this cosmetic side effect. Your doctor can help determine if alternative medications are available or if the darkening is acceptable given the medication's importance.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details